MedPath

Early Integrated Telehealth Versus In-Person Palliative Care for Patients With Lung Cancer

Not Applicable
Completed
Conditions
Lung Cancer
Interventions
Other: Telehealth
Other: In-person PC
Registration Number
NCT03375489
Lead Sponsor
Massachusetts General Hospital
Brief Summary

This research study is evaluating ways to provide palliative care to patients who have recently been diagnosed with lung cancer and their families.

Detailed Description

Patients with serious cancers, like advanced lung cancer, often experience physical symptoms, such as pain or shortness of breath. In addition, both patients and their loved ones (family and friends) often feel worried or sad about the cancer diagnosis.

Research has shown that early involvement of a team of clinicians that specialize in lessening (or "palliating") many of these distressing physical and emotional symptoms and in helping patients and their families cope with a serious illness improves patients' and their loved ones' experience with their cancer. This team is called "palliative care," and consists of physicians and advanced practice nurses (or "nurse practitioners") who work closely and collaboratively with the oncology team to care for the participant and the participant's loved ones. Research shows that when the palliative care team works closely with the oncology team to care for patients with advanced cancer, they have better symptom control, quality of life, and mood, and their loved ones feel less distressed. the investigators call this model of care, "early integrated palliative care."

While the investigators know that having palliative care clinicians work closely with the oncology team is helpful for patients and their loved ones, many patients do not have access to these specialists because hospitals and cancer clinics lack enough staff and because some patients and family members live in distant regions that make attending clinic visits difficult and expensive. One way to overcome these barriers is to have patients meet with palliative care clinicians using secure video-conferencing technology.

The purpose of this study is to determine if meeting with a palliative care clinician through video-conferencing is just as beneficial for patients and their families as meeting with a palliative care clinician in person. Specifically, this study will compare these two different strategies for meeting with the palliative care clinician. The first strategy is to schedule the participant to meet with the palliative care clinician regularly each month in person at the clinic. The investigators call this strategy "In-person palliative care."

The second strategy is to schedule the participant to meet with the palliative care clinician regularly each month using secure video-conferencing, such as through a smart phone or tablet computer. If the participant do not have this form of technology, the investigators will provide it for the participant. The investigators call this strategy "telehealth palliative care." The primary goals of this study are to learn if telehealth palliative care is just as effective as in-person palliative care for improving quality of life, mood symptoms, and satisfaction with care for patients with advanced lung cancer and their families.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1798
Inclusion Criteria
  • Patient Eligibility Criteria

    • Diagnosed with advanced non-small cell lung cancer being treated with non-curative intent, and informed of advanced disease within the prior twelve weeks
    • Eastern Cooperative Oncology Group (ECOG) Performance Status from 0 (asymptomatic) to 3 (symptomatic and in bed >50% of the day)
    • The ability to read and respond to questions in English or Spanish
    • Receiving primary cancer care at one of the participating sites
    • Age > or = 18 years
    • Lives in a state where their institutions' palliative care clinicians are licensed to practice
  • Caregiver Eligibility Criteria

    • Relative or friend who is identified by the patient participant and lives with the patient or has contact with them at least twice per week
    • The ability to read and respond to questions in English or Spanish
    • Age > or = 18 years
Exclusion Criteria
  • Patient Exclusion Criteria

    • Already receiving outpatient palliative care or hospice services
    • Cognitive or psychiatric conditions as determined by the treating oncologist to prohibit study consent or participation
  • Caregiver Exclusion Criteria

    • Cognitive or psychiatric conditions as determined by the treating oncologist to prohibit study consent or participation

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
TelehealthTelehealth* Patients will meet with the PC clinician in person within four weeks of enrollment * Subsequent visits with the PC clinician will be conducted with the patients in their home or other location using video at least every four weeks * Patients may be scheduled to meet with the PC clinician in the clinic if requested by the patient or a clinician
In Person PCIn-person PC* Patients will be scheduled for their first In-person PC visit within four weeks of enrollment and then at least every four weeks thereafter until the patient is no longer coming into the clinic * PC visits will be scheduled on the same day as an oncology visit if possible
Primary Outcome Measures
NameTimeMethod
Patient-reported Quality of Life24 Weeks

Compare the difference between study groups in patient-reported quality of life as measured by the Functional Assessment of Cancer Therapy - Lung Questionnaire, which has a total scale score range from 0-136 with higher scores indicating better overall quality of life.

Secondary Outcome Measures
NameTimeMethod
Patient-reported Satisfaction With Care24 weeks

Compare the difference between study groups in patient-reported satisfaction with care as measured by the Satisfaction and Care Delivery Questionnaire, which has a total scale score range from 0-52 with higher scores indicating greater satisfaction.

Patient-reported Communication About Their End-of-Life Care Preferences With Their Clinicians48 weeks (or last assessment prior to death if before 48 weeks)

Compare the difference between study groups in the proportion of patients who reported that they discussed their end-of-life care preferences with their clinicians based on a single item from the Prognosis and Treatment Perceptions Questionnaire (PTPQ). The PTPQ includes a self-report item that assesses whether the patient communicated with their clinicians about their wishes for care if they were dying (i.e., scored dichotomously as "yes vs. no").

Proportion of Patient's Palliative Care Visits With a Caregiver Present24 weeks

Compare the difference between study groups in the proportion of palliative care visits that had a caregiver present as documented by the palliative care clinician using a study visit summary form.

Length of Stay in HospiceFrom hospice enrollment until patient death during study period

Compare the difference between study groups in the length of stay in hospice (as measured in days) among patients who died during study period per medical record review.

Caregiver-reported Satisfaction With Care24 weeks

Compare the difference between study groups in caregiver-reported satisfaction with care as measured by the Satisfaction and Care Delivery Questionnaire (caregiver version), which has a total scale score range from 0-48 with higher scores indicating greater satisfaction.

Trial Locations

Locations (23)

Emory University

🇺🇸

Atlanta, Georgia, United States

UT Southwestern Medical Center

🇺🇸

Dallas, Texas, United States

City of Hope

🇺🇸

Los Angeles, California, United States

Johns Hopkins Medicine

🇺🇸

Baltimore, Maryland, United States

Dartmouth-Hitchcock Health

🇺🇸

Lebanon, New Hampshire, United States

Fox Chase Cancer Center

🇺🇸

Philadelphia, Pennsylvania, United States

University of Virginia

🇺🇸

Charlottesville, Virginia, United States

University of Wisconsin

🇺🇸

Madison, Wisconsin, United States

University of Alabama at Birmingham

🇺🇸

Birmingham, Alabama, United States

University of California - San Francisco

🇺🇸

San Francisco, California, United States

Northwestern University School of Medicine

🇺🇸

Chicago, Illinois, United States

Rush University Medical Center

🇺🇸

Chicago, Illinois, United States

Massachusetts General Hospital

🇺🇸

Boston, Massachusetts, United States

Dana Farber Cancer Institute

🇺🇸

Boston, Massachusetts, United States

Cleveland Clinic

🇺🇸

Cleveland, Ohio, United States

Vanderbilt University

🇺🇸

Nashville, Tennessee, United States

Mayo Clinic in Rochester

🇺🇸

Rochester, Minnesota, United States

University of North Carolina at Chapel Hill

🇺🇸

Chapel Hill, North Carolina, United States

University of Texas at Austin

🇺🇸

Austin, Texas, United States

University of Colorado

🇺🇸

Aurora, Colorado, United States

Wake Forest University

🇺🇸

Winston-Salem, North Carolina, United States

University of Michigan

🇺🇸

Ann Arbor, Michigan, United States

University of Kansas Medical Center

🇺🇸

Westwood, Kansas, United States

© Copyright 2025. All Rights Reserved by MedPath